Michiel M Eijsvogel1, Sytske Wiegersma2, Winfried Randerath3, Johan Verbraecken4, Esther Wegter-Hilbers5, Job van der Palen6. 1. Department of Pulmonology and Sleep Medicine, Medisch Spectrum Twente Hospital, Enschede, The Netherlands. 2. MIRA-Institute for Biomedical Technology & Technical Medicine, University of Twente, Enschede, The Netherlands. 3. Institute for Pneumology at the University Witten/Herdecke, Clinic for Pneumology and Allergology, Centre of Sleep Medicine and Respiratory Care, Bethanien Hospital, Solingen, Germany. 4. Department of Pulmonary Medicine and Multidisciplinary Sleep Disorders Centre, Antwerp University Hospital and University of Antwerp, Belgium. 5. Occupational Health Service Provider, HumanCapitalCare B.V., Son, The Netherlands. 6. Department of Epidemiology, Medisch Spectrum Twente Hospital, Enschede; Department of Research Methodology, Measurement and Data Analysis, University of Twente, Enschede, The Netherlands.
Abstract
STUDY OBJECTIVES: To develop and evaluate a screening questionnaire and a two-step screening strategy for obstructive sleep apnea syndrome (OSAS) in healthy workers. METHODS: This is a cross-sectional study of 1,861 employees comprising healthy blue- and white-collar workers in two representative plants in the Netherlands from a worldwide consumer electronic company who were approached to participate. Employees were invited to complete various sleep questionnaires, and undergo separate single nasal flow recording and home polysomnography on two separate nights. RESULTS: Of the 1,861 employees, 249 provided informed consent and all nasal flow and polysomnography data were available from 176 (70.7%). OSAS was diagnosed in 65 (36.9%). A combination of age, absence of insomnia, witnessed breathing stops, and three-way scoring of the Berlin and STOPBANG questionnaires best predicted OSAS. Factor analysis identified a six-factor structure of the resulting new questionnaire: snoring, snoring severity, tiredness, witnessed apneas, sleep quality, and daytime well-being. Subsequently, some questions were removed, and the remaining questions were used to construct a new questionnaire. A scoring algorithm, computing individual probabilities of OSAS as high, intermediate, or low risk, was developed. Subsequently, the intermediate risk group was split into low and high probability for OSAS, based on nasal flow recording. This two-step approach showed a sensitivity of 63.1%, and a specificity of 90.1%. Specificity is important for low prevalence populations. CONCLUSION: A two-step screening strategy with a new questionnaire and subsequent nasal flow recording is a promising way to screen for OSAS in a healthy worker population. CLINICAL TRIAL REGISTRATION: Development and validation of a screening instrument for obstructive sleep apnea syndrome in healthy workers. Netherlands Trial Register (www.trailregister.nl), number: NTR2675.
STUDY OBJECTIVES: To develop and evaluate a screening questionnaire and a two-step screening strategy for obstructive sleep apnea syndrome (OSAS) in healthy workers. METHODS: This is a cross-sectional study of 1,861 employees comprising healthy blue- and white-collar workers in two representative plants in the Netherlands from a worldwide consumer electronic company who were approached to participate. Employees were invited to complete various sleep questionnaires, and undergo separate single nasal flow recording and home polysomnography on two separate nights. RESULTS: Of the 1,861 employees, 249 provided informed consent and all nasal flow and polysomnography data were available from 176 (70.7%). OSAS was diagnosed in 65 (36.9%). A combination of age, absence of insomnia, witnessed breathing stops, and three-way scoring of the Berlin and STOPBANG questionnaires best predicted OSAS. Factor analysis identified a six-factor structure of the resulting new questionnaire: snoring, snoring severity, tiredness, witnessed apneas, sleep quality, and daytime well-being. Subsequently, some questions were removed, and the remaining questions were used to construct a new questionnaire. A scoring algorithm, computing individual probabilities of OSAS as high, intermediate, or low risk, was developed. Subsequently, the intermediate risk group was split into low and high probability for OSAS, based on nasal flow recording. This two-step approach showed a sensitivity of 63.1%, and a specificity of 90.1%. Specificity is important for low prevalence populations. CONCLUSION: A two-step screening strategy with a new questionnaire and subsequent nasal flow recording is a promising way to screen for OSAS in a healthy worker population. CLINICAL TRIAL REGISTRATION: Development and validation of a screening instrument for obstructive sleep apnea syndrome in healthy workers. Netherlands Trial Register (www.trailregister.nl), number: NTR2675.
Authors: Fernanda Ribeiro de Almeida; Najib T Ayas; Ryo Otsuka; Hiroshi Ueda; Peter Hamilton; Frank C Ryan; Alan A Lowe Journal: Sleep Breath Date: 2006-06 Impact factor: 2.816
Authors: Laila Simpson; David R Hillman; Matthew N Cooper; Kim L Ward; Michael Hunter; Stewart Cullen; Alan James; Lyle J Palmer; Sutapa Mukherjee; Peter Eastwood Journal: Sleep Breath Date: 2012-11-16 Impact factor: 2.816
Authors: Liseth Siemons; Peter M ten Klooster; Erik Taal; Ina H Kuper; Piet L C M van Riel; Mart A F J van de Laar; Cees A W Glas Journal: J Rheumatol Date: 2011-10-01 Impact factor: 4.666
Authors: Douglas C Cowan; Gwen Allardice; Duncan Macfarlane; Darren Ramsay; Heather Ambler; Stephen Banham; Eric Livingston; Christopher Carlin Journal: BMJ Open Date: 2014-04-15 Impact factor: 2.692
Authors: Floris A J Geessinck; Rick G Pleijhuis; Rob J Mentink; Job van der Palen; Hendrik Koffijberg Journal: J Clin Sleep Med Date: 2018-06-15 Impact factor: 4.062
Authors: Britta D P J Maas; Tjasse D Bruintjes; Hester J van der Zaag-Loonen; Roeland B van Leeuwen Journal: Eur Arch Otorhinolaryngol Date: 2020-02-18 Impact factor: 2.503
Authors: Hui Chen; Yingguang Li; Johan Hc Reiber; Jan de Lange; Shengxian Tu; Paul van der Stelt; Frank Lobbezoo; Ghizlane Aarab Journal: Dentomaxillofac Radiol Date: 2018-01-02 Impact factor: 2.419
Authors: Timon M Fabius; Jeffrey R Benistant; Lindsey Bekkedam; Job van der Palen; Frans H C de Jongh; Michiel M M Eijsvogel Journal: Sleep Breath Date: 2018-03-21 Impact factor: 2.816
Authors: Timon M Fabius; Jeffrey R Benistant; Rick G Pleijhuis; Job van der Palen; Michiel M M Eijsvogel Journal: Sleep Breath Date: 2019-04-06 Impact factor: 2.816
Authors: Alexandru Topîrceanu; Mihai Udrescu; Lucreţia Udrescu; Carmen Ardelean; Rodica Dan; Daniela Reisz; Stefan Mihaicuta Journal: PLoS One Date: 2018-09-05 Impact factor: 3.240